Isaac Bentwich, M.D., Founder and Chief Architect of Rosetta Genomics, Ltd., presides over the Market Closing Bell

Tuesday, February 27, 2007
at NASDAQ's MarketSite
in New York City.

Rosetta Genomics, Ltd.
[ROSG]

Isaac Bentwich, M.D., Founder and Chief Architect of Rosetta Genomics, Ltd.(ROSG) presides over the closing bell to celebrate the company's initial public offering on NASDAQ. Rosetta Genomics Ltd. listed on February 26, 2007.

Rosetta Genomics is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs, which are believed to play an important role in regulating protein production. Rosetta has developed an early and strong intellectual property position related to the development and commercialization of microRNA-based products. Rosetta's current programs are focused on the development of microRNA-based diagnostic and therapeutic products for various cancers and infectious diseases.

Reprints

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 02/27/2007 Download Hi-Res Quality Photo of this NASDAQ Market Open - Pictured: Isaac Bentwich, M.D., Founder and Chief Architect of Rosetta Genomics, Ltd., Rings The NASDAQ Stock Market Closing Bell. These photos are Copyright 2007, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2007, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.